Buch & Holm

AmeRuss Clinical Trials, LLC (headquartered in the US, Arizona) is a next generation CRO that provides comprehensive integrated clinical development solutions to Pharma, Biotech and Medical Device companies.

AmeRuss successfully operates in Russia, CIS, Baltic States, Europe, Caucasia and MENA countries.

We have the capability to conduct full service clinical trials from phase I to phase IV (including observational NIS, registries, Investigator Initiated Studies) and bring the highest quality standards at every step of the trial: protocol design, monitoring, project management, data management, statistical analysis, QA, Pharmacovigilance, Clinical Logistics, GCP trainings, publications, etc.

As a sponsor, you can expect a deep personal attention, flexible approach and a high quality work done within tough timelines.

AmeRuss is a ISO 9001-2008 certified company, and acts in accordance with the international standards and guidance such as ICH GCP, ISO 14155:2011 and other local regulatory requirements.

Please, visit us at:
www.ameruss.com

Global provider of custom biological products and services for Cell Culture Services, Gene-Editing , Human Biospecimens, Cell and Tissue Preparations and Analyses, and Sample Storage and Logistics.

~Animal and Human Cells

~Human Tissues; and Extracts From Cells and Tissues
-Cellular Membranes
-Proteins
-RNA
-DNA

~Services include
-Cell Culture
-Biobanking
-Human Tissue and Clinical Data Acquisitions
-Histology and Immunohistochemistry
-Cellular extracts and membrane preparations

~Other Biological Research Services Include
-Provision of Trained Laboratory Staff to Work in Clients’ Laboratories.

CordenPharma is your full-service partner in the Contract Development & Manufacturing (CDMO) of APIs, Drug Products and associated Packaging Services. Through a network of cGMP facilities across Europe and the US organized under four technology platforms – Peptides, Lipids & Carbohydrates – Injectables - Highly Potent & Oncology - Small Molecules - CordenPharma experts translate complex ideas, processes and projects at any stage of development into high-value products.

<< Peptides, Lipids & Carbohydrates >>

• Synthetic Peptide API Production
- Solid-phase, Liquid-phase, Hybrid Synthesis
- cGMP & non-cGMP
• Synthetic Lipids
• Carbohydrates

<< Sterile Injectables >>

• New Development & Commercial Suites for Aseptic Filling with > 60.000 units
per day (Pre-filled Syringes, Liquid or Lyophilized Vials)
• Packaging, Labeling & Logistics
• Sterile Emulsion Technology
• Large Pre-Filled Syringes
• Clinical Trial Services

<< Highly Potent & Oncology >>

• API Development & Commercial Manufacturing
(SafeBridge Category 4, OEL ≤1 ng/m3)
- New Development & Scale-up Capacity for Phase I/II Supply
• Drug Product Development & Manufacturing
- New Development Suite (CTD2) for Mid-scale Oral Dosage (up to 20 kg)
- Sterile Liquid & Lyophilization
- Primary & Secondary Packaging

<< Small Molecules >>

• Development & Commercial Manufacturing
- Intermediates
- APIs & Excipients
- Clinical Supply Phases I-III
• Proprietary & Generic Advanced Intermediates & APIs

Visit > www.cordenpharma.com

DKSH’s purpose is to enrich people’s lives by providing access to goods, services, and insights. United by our vision to be the trusted partner, we help companies grow in Asia and beyond across our Business Units Consumer Goods, Healthcare, Performance Materials, and Technology.

Delivering life-saving drugs to hospitals, bringing high-quality products to remote villages, installing technology that raises living standards, and providing new formulations for healthcare products that make life easier. These are just a few examples of how DKSH touches people’s lives around the clock. We do this while helping our clients and customers grow by providing services including sourcing, market insights, marketing and sales, eCommerce, distribution and logistics as well as after-sales services.

Listed on the SIX Swiss Exchange, DKSH operates in 36 markets with 32,450 specialists, generating net sales of CHF 10.7 billion in 2020. Founded by Swiss entrepreneurs in 1865, we have been deeply rooted in Asia Pacific for over 150 years.

Delivering Growth – in Asia and Beyond.


Join us today.
DKSH’s strength lies in our great diversity of services, industries, clients, products, regions, and employees from various cultures. We are proud of our people: they are the best in the industry and the reason for our business success. They are passionate, energetic, and purposeful, positively touching millions of lives through the products and services we provide. Join us today if you are ready to “Drive Growth. Be the Difference.” With DKSH, you will experience a world of learning and development, own your career and take business responsibility, and have a positive impact that touches people’s lives.

hameln pharma ltd is a leading supplier of high quality sterile generic medicines to the UK secondary healthcare sector.

With almost 50 years experience of supplying the NHS, hameln is committed to delivering quality, consistency and reliability throughout its operations. As an example, we utilise our own warehousing and logistics facilities, which help to ensure consistently high levels of supply reliability.

Patient safety is at the forefront of every element of the hameln service from intelligent packaging design to ready-to-use products focussed on reducing the potential for medication errors.